Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/01/2007US20070253968 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, DNA and viruses
11/01/2007US20070253966 Fusion Proteins
11/01/2007US20070253965 Reagents for Diagnosis and Therapy of Latex Allergy and Method for the Preparation of the Same
11/01/2007US20070253964 Novel Immunogenic Compositions for the Prevention and Treatment of Meningococcal Disease
11/01/2007US20070253963 Epithelial cell specific growth factor keratinocyte growth factor (KGF)
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253945 lysozyme produced from a Chalaropsis species of fungi, having a corrected amino acid sequence so as to allow recombinant production of this enzyme with a higher activity; antibacterial agent in applications wherein killing of highly resistant bacteria such as methicillin-resistant is desired
11/01/2007US20070253935 Surface expression method of peptides p5 and anal3 using the gene encoding poly-gamma-glutamate synthetase
11/01/2007US20070253933 Carotene Synthase Gene and Uses Therefor
11/01/2007US20070253932 Recombinant adenoviral vectors and methods of use
11/01/2007US20070253929 Derivatives of growth hormone and related proteins, and methods of use thereof
11/01/2007US20070253912 Process for the preparation of micronised collagen, and its therapeutic applications
11/01/2007US20070253902 Treatment for inflammatory bowel disease
11/01/2007US20070253901 Atherosclerosis genes and related reagents and methods of use thereof
11/01/2007US20070253900 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
11/01/2007CA2800389A1 Glp-1 compounds
11/01/2007CA2650079A1 A sex-specific marker for shrimps and prawns
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649770A1 Mutated acvr1 for diagnosis and treatment of fibrodyplasia ossificans progressiva (fop)
11/01/2007CA2649751A1 Glp-1 compound/glucagon antibody compositions
11/01/2007CA2649734A1 Isolated polynucleotide molecules corresponding to mutant and wild-type alleles of the maize d9 gene and methods of use
11/01/2007CA2649589A1 Novel polypeptides and use thereof
11/01/2007CA2649555A1 Hpv-18-based papillomavirus vaccine
11/01/2007CA2649535A1 Thermostable proteins and methods of making and using thereof
11/01/2007CA2649392A1 Papillomavirus vaccine
11/01/2007CA2648936A1 Glp-1 compounds
11/01/2007CA2648915A1 Tetramerizing polypeptides and methods of use
11/01/2007CA2648558A1 Molecular dissection of the role of the pi3-kinase/akt pathway; redirection from pro-survival signaling to a death pathway through nuclear relocation of akt
11/01/2007CA2648499A1 Transgenic plants and methods for controlling bolting in sugar beet
11/01/2007CA2648096A1 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/01/2007CA2645853A1 Methods of determining cellular chemosensitivity
11/01/2007CA2645832A1 Hcv vaccinations
11/01/2007CA2637222A1 Expression control elements from the lemnaceae family
10/2007
10/31/2007EP1850133A1 Method for determining high ristocetin cofactor activity of the von Willebrand factor
10/31/2007EP1849872A1 Adeno-associated virus vectors and uses thereof
10/31/2007EP1849870A1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM)
10/31/2007EP1849869A2 Nucleotide sequences of HIV-1 group (or sub-group) 0 retroviral antigens
10/31/2007EP1849868A2 Plant defensins
10/31/2007EP1849866A2 Human orphan G protein-coupled receptors
10/31/2007EP1849802A2 Methods for altering fertility
10/31/2007EP1849801A1 Tyrosine-based motif and clostridial neurotoxins
10/31/2007EP1849800A2 Moraxella catarrhalis proteins
10/31/2007EP1849799A1 Modified virus capsid protein and the use thereof
10/31/2007EP1849798A1 Cell permeable peptide
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1848831A2 Elisa assays using prion-specific peptide reagents
10/31/2007EP1848830A2 Osplation of pathogenic prions
10/31/2007EP1848804A2 Anti-muci alpha beta antibodies
10/31/2007EP1848800A2 Novel gene vcs 02
10/31/2007EP1848743A2 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
10/31/2007EP1848738A1 Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes
10/31/2007EP1848737A2 Homogeneous preparations of il-31
10/31/2007EP1848736A2 Salt taste receptor and its use in an assay for salt taste
10/31/2007EP1848735A1 Polypeptides having alpha-amylase and granular starch hydrolyzing activity
10/31/2007EP1848734A2 Method for coating surfaces with hydrophobins
10/31/2007EP1848733A2 Novel hydrophobin fusion products, production and use thereof
10/31/2007EP1848732A2 Yersinia spp. polypeptides and methods of use
10/31/2007EP1848731A1 Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof
10/31/2007EP1848504A2 Wound treatment device for photodynamic therapy and method of using same
10/31/2007EP1848265A2 Plant defense signal peptides
10/31/2007EP1697406A4 Protein separation device
10/31/2007EP1680446B1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens
10/31/2007EP1546195B1 Improved mutants of biotin binding protein
10/31/2007EP1534737A4 Peptide antagonists of tgf-beta family members and therapeutic uses thereof
10/31/2007EP1509606B1 Allergen from mugwort pollen
10/31/2007EP1414857A4 Factor viii separation
10/31/2007EP1372691B1 Mucin peptide with immunoenhancing properties
10/31/2007EP1362915B1 Nomuraeae rileyi -origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same
10/31/2007EP1259626B1 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
10/31/2007EP1255838B1 Dehiscence gene and methods for regulating dehiscence
10/31/2007EP1183346B1 Method for generating split, non-transferable genes that are able to express an active protein product
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1165791B1 Human cytokine as ligand of the zalpha receptor and uses thereof
10/31/2007EP1131422B1 Recombinant glycoproteins, method for the production thereof, medicaments containing said glycoproteins and use thereof
10/31/2007EP1105511B1 Transgenic plants and plant cells comprising a reduced expression of invertase inhibitors
10/31/2007EP1078004B1 Tetravalent antibody constructs
10/31/2007EP1064020A4 Methods for diagnosing and treating autoimmune disease
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP1012189B1 Treatment of obesity
10/31/2007EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007EP0851030B9 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
10/31/2007DE19515310B4 Isoelastische Hüftendoprothese Isoelastic hip replacement
10/31/2007DE10014639B4 cDNSen mit einer Kodierung von Enzymen zur Fructan-Synthese mit einer Niedertemperatur-Expression sowie Verfahren zu deren Isolierung cDNSen with a coding for enzymes of fructan synthesis with a low-temperature expression as well as methods for their isolation
10/31/2007CN101065401A Osteoprotegerin variant proteins
10/31/2007CN101065400A Genetically engineered cells for therapeutic applications
10/31/2007CN101065399A Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
10/31/2007CN101065398A Peptides and APL-type derivatives of hsp60 and pharmaceutical compositions
10/31/2007CN101065397A A bacterial ATP synthase binding domain
10/31/2007CN101065145A A chimeric G protein based rabies vaccine
10/31/2007CN101065133A Pancreatic polypeptide family motifs and polypeptides comprising the same
10/31/2007CN101063147A Yeast expression carrier for recombined bone sialic acid protein and its application
10/31/2007CN101063146A Yeast expression carrier for combined bone sialic acid protein, purification method and its application
10/31/2007CN101063145A Expression carrier for black porgy antibiotic peptide Hepcidin and expression product and constructing preparation method
10/31/2007CN101063143A Recombined cytomegalovirus gp52 protein and its application
10/31/2007CN101063141A Moraxella(branhamella) catarrhalis antigens
10/31/2007CN101063132A Lateolabrax interleukins 8 gene order
10/31/2007CN101063131A Lateolabrax agglutinin gene order
1 ... 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 ... 2916